Cannabinoids as Antioxidants and Neuroprotectants, Exclusive license US Patent 66305071-10 Employees
- B2C
- Early StageStartup in initial stages
KannaLife Sciences Funding
$1.5M
11 round
KannaLife Sciences is active in the following markets / industries: biotechnology, life sciences, pharmaceuticals and cosmetics. The company has secured funding across 1 rounds, totaling in an amount of $1.5M. Their most recent funding was raised on March 7, 2013.
Funding Rounds
A
$1500000